ALCORA B.V. backed the London-based recruitment technology startup in its latest funding round.
"Vinter offers a more streamlined and transparent recruitment process for both candidates and recruitment teams. Our flexible platform allows recruiters to customise their hiring processes while promoting data-driven decision-making. Thanks to Vinter’s asynchronous system, both candidates and recruiters can progress at their convenience, without the need for scheduled meetings or appointments. Our regular status updates ensure all parties are informed about the hiring process at every stage."
The funding round was led by Nickleby Capital to support the platform's expansion in premium ticketing.
"Here at Seat Unique we’re looking forward to working closely with 4CAST. It’s a dream partnership for us with a brilliant group of stars in its books. Together, we’ll be able to join forces to combine the reach and influence of the many talented sporting professionals associated with 4CAST with our future plans at Seat Unique. Their support will give us the unique opportunity to establish close collaborations with esteemed athletes, amplifying our brand visibility and showcasing the exceptional experiences offered on our platform to new audiences."
The round was co-led by IQ Capital and Plural to support team expansion and pilot manufacturing.
"The promise of lithium-sulfur batteries has been envisaged for decades but until now it has not been possible to realise this potential because of the inherent chemistry challenges of working with sulfur. By utilising MoS2 we have achieved a groundbreaking milestone in battery technology innovation and are on track to bring this new battery chemistry to the market, creating batteries that will end range anxiety. We have an unrivalled founding team, which between us has years of commercial and research experience, along with insightful advisers and world-leading investors. Now we have the right backing to go forward and disrupt the industry for the better."
The oversubscribed round was backed by MMC Ventures, Molten VC, Simplyhealth Ventures, and KHP Ventures.
"Today’s announcement of our heavily oversubscribed investment round is a major endorsement of our incredible technology and our journey to date. We are delighted to see such healthy interest in our vision of revolutionising access to screening from the investment community and we’re thrilled to have Molten Ventures, MMC Ventures, and Simplyhealth Ventures investing. The inclusion of KHP Ventures as a fund backed by NHS institutions is a clear signal of our NHS traction and alignment with overall NHS priorities – we couldn’t be happier that they’re investing in our journey."
